beta

You're viewing our new website - find out more

Publication - Consultation Paper

Clinical Trial Access quality performance indicator: consultation

Published: 3 Jul 2017
Part of:
Health and social care
ISBN:
9781788510912

Consultation on the effectiveness of the Clinical Trial Access quality performance indicator (QPI) as part of the National Cancer QPIs.

20 page PDF

492.4kB

20 page PDF

492.4kB

Contents
Clinical Trial Access quality performance indicator: consultation
Appendix 6 - Yearly National Governance Process & Improvement Framework for Cancer Care

20 page PDF

492.4kB

Appendix 6 - Yearly National Governance Process & Improvement Framework for Cancer Care

This process is underpinned by the annual regional reporting and governance framework (see appendix 6).

Yearly National Governance Process & Improvement Framework for Cancer Care

1. National QPI Development Stage

  • QPIs developed by QPI development groups, which include representation from Regional Cancer Networks, Healthcare Improvement Scotland, ISD, patient representatives and the Cancer Coalition.

2. Data Analysis Stage:w

  • NHS Boards and Regional Cancer Advisory Groups ( RCAGs)* collect data and analyse on yearly basis using nationally agreed measurability criteria and produce action plans to address areas of variance, see appendix 6.
  • Submit yearly reports to ISD for collation and publication every 3 years.
  • National comparative report approved by NHS Boards and RCAGs.
  • ISD produce comparative, publicly available, national report consisting of trend analysis of 3 years data and survival analysis.

3. Expert Review Group Stage (for 3 tumour types per year):

  • Expert group, hosted by Healthcare Improvement Scotland, review comparative national results.
  • Write to RCAGs highlighting areas of good practice and variances.
  • Where required NHS Boards requested to submit improvement plans for any outstanding unresolved issues with timescales for improvement to expert group.
  • Improvement plans ratified by expert group and Scottish Cancer Taskforce.

4. Improvement Support Stage:

  • Where required Healthcare Improvement Scotland provide expertise on improvement methodologies and support.

5. Monitoring Stage:

  • RCAGs work with Boards to progress outstanding actions, monitor improvement plans and submit progress report to Healthcare Improvement Scotland.
  • Healthcare Improvement Scotland report to Scottish Cancer Taskforce as to whether progress is acceptable .

6. Escalation Stage:

  • If progress not acceptable, Healthcare Improvement Scotland will visit the service concerned and work with the RCAG and Board to address issues.
  • Report submitted to Scottish Cancer Taskforce and escalation with a proposal to take forward to Scottish Government Health Department.

*In the South and East of Scotland Cancer Network ( SCAN) the Regional Cancer Planning Group is the equivalent group to Regional Cancer Advisory Group ( RCAG).


Contact

Email: Chris Booth, chris.booth@gov.scot

Phone: 0300 244 4000 – Central Enquiry Unit

The Scottish Government
St Andrew's House
Regent Road
Edinburgh
EH1 3DG